Annick Harel-Bellan

Title: Annick Harel-Bellan: Innovator in Cancer Treatment

Introduction

Annick Harel-Bellan is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. With a total of 2 patents, her work focuses on developing targeted therapies that aim to combat cancer at the molecular level.

Latest Patents

Harel-Bellan's latest patents include groundbreaking advancements in siRNA-based cancer treatment. One of her patents describes a double-strand oligonucleotide that includes two complementary oligonucleotide sequences forming a hybrid. Each sequence contains unpaired nucleotides at one of their ends, extending beyond the hybrid. This invention specifically targets DNA or RNA molecules associated with angiogenic factors, providing a novel approach to cancer therapy. Another patent outlines a method for treating diseases caused by harmful gene expression. This method involves administering a pharmaceutical composition containing double-stranded oligonucleotides that target mutated or nonmutated androgen receptors, showcasing her commitment to advancing cancer treatment.

Career Highlights

Annick Harel-Bellan is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.

Collaborations

Harel-Bellan collaborates with esteemed colleagues, including Slimane Ait-Si-Ali and Florence Cabon-Georget. These partnerships enhance her research efforts and contribute to the development of innovative solutions in cancer treatment.

Conclusion

Annick Harel-Bellan's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the field. Her work continues to inspire advancements in medical research and therapy.